GCP
GNPX icon

GSA Capital Partners’s Genprex GNPX Stock Holding History

GSA Capital Partners’s Portfolio GNPX Stock Details GNPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3
Closed -$279K – 1549
2022
Q1 		$279K Sell
3
-4
-57% -$390K 0.04% 947
2021
Q4 		$398K Sell
7
-2
-22% -$167K 0.05% 747
2021
Q3 		$1.1M Buy
+9
New +$1.17M 0.11% 266

Other funds holding GNPX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Cypress Capital Franklin, Tennessee $370M AUM 16.36% 1-Year Est. Return
VCP
Verus Capital Partners Scottsdale, Arizona $1.46B AUM 27.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GSA Capital Partners's GNPX Position: Q2 2022 in Review

GSA Capital Partners sold out of Genprex (GNPX) in Q2 2022, closing a stake of 3 shares — an estimated $279K sold.

GSA Capital Partners first reported a position in GNPX in Q3 2021 and held it in 3 quarters. The position peaked at $1.1M in Q3 2021. 20 funds tracked by Wall St. Rank hold GNPX as of Q2 2022.

  • GSA Capital Partners reported no remaining Genprex position as of Q2 2022 after selling out during the quarter.
  • GSA Capital Partners sold 3 Genprex shares in Q2 2022, an estimated $279K.
  • GSA Capital Partners first reported a position in Genprex in Q3 2021 and held it in 3 quarters.
  • GSA Capital Partners's Genprex position peaked at $1.1M in Q3 2021.
  • 20 funds tracked by Wall St. Rank held Genprex as of Q2 2022.

Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.